Cyclooxygenase in normal human tissues--is COX-1 really a constitutive isoform, and COX-2 an inducible isoform?
about
NSAIDs and Cardiovascular Diseases: Role of Reactive Oxygen SpeciesCurrent perspectives in NSAID-induced gastropathyE-type prostanoid receptor 4 (EP4) in disease and therapyEpigenetic regulations of inflammatory cyclooxygenase-derived prostanoids: molecular basis and pathophysiological consequencesCyclooxygenase-2 and cancer treatment: understanding the risk should be worth the rewardEffect of formulation variables on preparation of celecoxib loaded polylactide-co-glycolide nanoparticlesA Randomized Placebo Controlled Trial of Ibuprofen for Respiratory Syncytial Virus Infection in a Bovine ModelEthyl cellulose nanoparticles as a platform to decrease ulcerogenic potential of piroxicam: formulation and in vitro/in vivo evaluationCyclooxygenase-deficient pancreatic cancer cells use exogenous sources of prostaglandins.Thrombosis is reduced by inhibition of COX-1, but unaffected by inhibition of COX-2, in an acute model of platelet activation in the mouseCyclooxygenases: structural and functional insights.TCDD induced pericardial edema and relative COX-2 expression in medaka (Oryzias Latipes) embryosRole of the cyclooxygenase pathway in chemotherapy-induced oral mucositis: a pilot studyUpregulation of prostaglandin receptor EP1 expression involves its association with cyclooxygenase-2Correlation of microRNA-16, microRNA-21 and microRNA-101 expression with cyclooxygenase-2 expression and angiogenic factors in cirrhotic and noncirrhotic human hepatocellular carcinomaPrognostic significance of cyclooxygenase-2 protein in pancreatic cancer: a meta-analysis.Anti-platelet therapy: cyclo-oxygenase inhibition and the use of aspirin with particular regard to dual anti-platelet therapyCyclooxygenase-1, not cyclooxygenase-2, is responsible for physiological production of prostacyclin in the cardiovascular system.Evidence that links loss of cyclooxygenase-2 with increased asymmetric dimethylarginine: novel explanation of cardiovascular side effects associated with anti-inflammatory drugsA tutorial on fatty acid biology.Valdecoxib : the rise and fall of a COX-2 inhibitor.Highly pathogenic porcine reproductive and respiratory syndrome virus induces prostaglandin E2 production through cyclooxygenase 1, which is dependent on the ERK1/2-p-C/EBP-β pathway.Management of NSAID-associated peptic ulcer disease.Cyclooxygenase metabolism mediates vasorelaxation to 2-arachidonoylglycerol (2-AG) in human mesenteric arteries.Phytochemical analysis and anti-inflammatory potential of Hyphaene thebaica L. fruit.The effect of tramadol and indomethacin coadministration on gastric barrier function in dogs.Systematic module approach identifies altered genes and pathways in four types of ovarian cancer.Spatial detection of fetal marker genes expressed at low level in adult human heart tissue.Enhancement on reactive oxygen species and COX-1 mRNA levels modulate the vascular relaxation induced by sodium nitroprusside in denuded mice aorta.Cardiovascular safety of non-steroidal anti-inflammatory drugs revisited.Prostaglandin-Endoperoxide Synthase 1 Mediates the Timing of Parturition in Mice Despite Unhindered Uterine Contractility.Pharmacokinetics and safety of single and multiple oral doses of meloxicam in adult horses.Effects of Nonsteroidal Anti-Inflammatory Drugs at the Molecular Level.Nitrogen-Doped Graphene Quantum Dot-Combined Sodium 10-Amino-2-methoxyundecanoate: Studies of Proinflammatory Gene Expression and Live Cell ImagingIn Vivo Brain Imaging, Biodistribution, and Radiation Dosimetry Estimation of [C]Celecoxib, a COX-2 PET Ligand, in Nonhuman Primates
P2860
Q26784322-D79BA345-12F5-4722-A5FC-3FE715D4AA20Q26827673-985F7D5D-6816-4439-B0E5-76032D1CB9C3Q26851156-F0E0E929-D5E5-4DF2-A6AD-1AECA88E4E0AQ26862642-5F79C018-D582-4C93-8A49-4DC24A1E426AQ28274081-F9CA8623-E550-42DB-A7A9-70AD6699788FQ28542696-E1E5E880-70D2-4528-AFB7-05B9FB983BA2Q28551334-C21DA9E7-6B45-4212-A3A2-E9356D4645ADQ28829681-0845E305-37FE-4F7A-BBA8-7821BE13521FQ30494961-0E628072-5671-4B7B-A7EF-582039588807Q33918377-C33E1A3B-4C6C-4C13-8731-01348E9E80F3Q34014369-440B0038-4697-4588-A1FE-E7F26BB34E78Q34200680-B7E755A3-3013-488E-9354-7A0FF5E78C68Q34553968-77D97817-06F5-4E97-94D1-F0E0DC04374DQ35116059-31B20A49-9606-4918-BE4D-4C110CB3C939Q35156115-2A8A34AC-AFC3-44AF-AD6A-FAE400613752Q35208554-3E196DDB-88F1-4F8C-A3D5-445F7ADF2A8FQ35373624-8DD56ED8-EA92-4FC3-B96A-9026A881CBE3Q36378519-D8165761-CAAF-4A7B-9CAB-860261D682B3Q36622844-D42A830C-F9B1-4C43-BB75-26286699DE37Q38013606-19C41BF0-8B9C-47B6-B0D0-7EC2AB24BBE0Q38091707-9BD329FB-70A2-48A6-831D-9AC167F3412CQ38330284-D4CF2785-8951-4867-8D22-34A1B94B76D2Q38699305-E185E930-AB8A-4B9F-AC7D-26045998E0AEQ38832242-F7750131-6F96-4338-B1F9-5A5D9E30F37BQ38999107-43F2C234-DC65-4290-A963-AE662B459D66Q41189002-69604637-AC54-46DB-9955-6BAABBCAB5E9Q41990579-19EAC724-0D49-4E93-9A4F-6BB36CF8509BQ42374965-8999258C-9110-4D6E-8AE7-C0FB15677FC5Q46782572-92F51684-2979-4E56-9C49-4B237F04C7D6Q47372560-BFA2D776-1D16-4BB8-82E9-5F785938B54AQ47447037-B3A708F5-1356-4CA8-9DE3-B55C55C7B8C2Q50922439-A3F10EA4-242F-42F7-94DC-8123B9B2B74FQ55531057-3CB23056-1652-4706-BA05-FD9D4521CEEAQ57489587-0725F589-7F07-4BE9-82AC-A8B5321878DCQ58697325-6C4FCB15-BF72-425C-93B6-633EA2F2F2DD
P2860
Cyclooxygenase in normal human tissues--is COX-1 really a constitutive isoform, and COX-2 an inducible isoform?
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Cyclooxygenase in normal human ...... nd COX-2 an inducible isoform?
@ast
Cyclooxygenase in normal human ...... nd COX-2 an inducible isoform?
@en
type
label
Cyclooxygenase in normal human ...... nd COX-2 an inducible isoform?
@ast
Cyclooxygenase in normal human ...... nd COX-2 an inducible isoform?
@en
prefLabel
Cyclooxygenase in normal human ...... nd COX-2 an inducible isoform?
@ast
Cyclooxygenase in normal human ...... nd COX-2 an inducible isoform?
@en
P2093
P2860
P1476
Cyclooxygenase in normal human ...... nd COX-2 an inducible isoform?
@en
P2093
Damjan Glavac
Dusan Stajer
Katarina Odar
Maja Jerse
Nina Zidar
Tomaz Zupanc
P2860
P304
P356
10.1111/J.1582-4934.2008.00430.X
P577
2008-07-24T00:00:00Z